Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility

Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility

Publication: J Pharm Sci
Software: GastroPlus®

ARRY-403 is a glucokinase activator developed for the treatment of diabetes. Less than dose-proportional exposure was observed during single ascending dose studies with ARRY-403.

Physiologically based pharmacokinetic modelling in drug discovery and development: A pharmaceutical industry perspective

Physiologically based pharmacokinetic modelling in drug discovery and development: A pharmaceutical industry perspective

Publication: Clin Pharmacol Ther
Software: GastroPlus®

The application of physiologically based pharmacokinetic (PBPK) modeling has developed rapidly within the pharmaceutical industry and is becoming an integral part of drug discovery and development.

Comparison of in silico tools for evaluating rat oral acute toxicity

Comparison of in silico tools for evaluating rat oral acute toxicity

Publication: SAR QSAR Environ Res
Software: ADMET Predictor®

Different in silico models have been developed and implemented for the evaluation of mammalian acute toxicity, exploring acute oral toxicity data expressed as median lethal dose (LD(50)).

The potency–insolubility conundrum in pharmaceuticals: Mechanism and solution for hepatitis C protease inhibitors

The potency–insolubility conundrum in pharmaceuticals: Mechanism and solution for hepatitis C protease inhibitors

Publication: Biophysical Chem
Software: GastroPlus®

As compounds are optimized for greater potency during pharmaceutical discovery, their aqueous solubility often decreases, making them less viable as orally-administered drugs.

The potency-insolubility conundrum in pharmaceuticals: Mechanism and solution for hepatitis C protease inhibitors

The potency-insolubility conundrum in pharmaceuticals: Mechanism and solution for hepatitis C protease inhibitors

Publication: Biophysical Chem
Software: GastroPlus®

As compounds are optimized for greater potency during pharmaceutical discovery, their aqueous solubility often decreases, making them less viable as orally-administered drugs.

Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems

Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems

Publication: Expert Opin Drug Metab Toxicol
Software: ADMET Predictor®

The therapeutic outcome of oximes used as reactivators of phosphorylated human acetylcholinesterase (AChE) is influenced, among other factors, by their biological distribution, their in vivo ability...

In vitro-in vivo correlations: general concepts, methodologies and regulatory applications

In vitro-in vivo correlations: general concepts, methodologies and regulatory applications

Publication: Drug Dev Ind Pharm

The major objective of in vitro-in vivo correlations is to be able to use in vitro data to predict in vivo performance serving as a surrogate for an in vivo bioavailability test and to support biowaivers.

Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function

Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function

Publication: Antimicrob Agents Chemother
Division: Cognigen

Prolonged treatment with the oxazolidinone linezolid is associated with myelosuppression, lactic acidosis, and neuropathies, toxicities likely caused by impairment of mitochondrial protein synthesis (MPS). To evaluate the potential of the novel oxazolidinone tedizolid...

MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics

MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics

Publication: Pharm Res
Software: MITOsym®
Division: DILIsym Services

MITOsym, a new mathematical model of hepatocellular respiration and bioenergetics, has been developed in partnership with the DILIsym® model with the purpose of translating in vitro compound screening data...

Predicting pharmacokinetics of anti-cancer drug, famitinib in human using physiologically based pharmacokinetic model

Predicting pharmacokinetics of anti-cancer drug, famitinib in human using physiologically based pharmacokinetic model

Publication: Yao Xue Xue Bao
Software: GastroPlus®

This study is to establish physiologically based pharmacokinetic (PBPK) models of famitinib in rat and monkey, and then to predict the pharmacokinetics and tissue distribution of famitinib in human based on the PBPK models.

Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein

Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein

Publication: SAR QSAR Environ Res
Software: ADMET Predictor®

P-glycoprotein (P-gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) are two members of the adenosine triphosphate (ATP) binding cassette (ABC) family of transporters which...

Novel Orally Swallowable IntelliCap(®) Device to Quantify Regional Drug Absorption in Human GI Tract Using Diltiazem as Model Drug

Novel Orally Swallowable IntelliCap(®) Device to Quantify Regional Drug Absorption in Human GI Tract Using Diltiazem as Model Drug

Publication: AAPS PharmSciTech
Software: GastroPlus®

Typically, colonic absorption of a drug is mandatory for a sustained release formulation to hold the drug's plasma level for more than 12 or 24 h above the minimum therapeutic plasma concentration (efficacy).

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology to Improve in silico pKa Prediction

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology to Improve in silico pKa Prediction

Publication: J Chem Inf Model
Software: ADMET Predictor®

In a unique collaboration between a software company and a pharmaceutical company, we were able to develop a new in silico pKa prediction tool with outstanding prediction quality.

A combination of pharmacophore modeling, molecular docking, and virtual screening for P2Y12 receptor antagonists from Chinese herbs

A combination of pharmacophore modeling, molecular docking, and virtual screening for P2Y12 receptor antagonists from Chinese herbs

Publication: Canadian J Chem
Software: ADMET Predictor®

P2Y12, a member of the G-protein-coupled receptors, is associated with abnormal platelet aggregation, a condition that contributes to thrombus formation.

Prediction and Comparison of Drug likeliness properties of Primaquine and its structural analogues using In-Silico ADME and Toxicity Prediction Tools

Prediction and Comparison of Drug likeliness properties of Primaquine and its structural analogues using In-Silico ADME and Toxicity Prediction Tools

Publication: J Adv Bioinf Appl Res
Software: ADMET Predictor®

Five primaquine (PQ) analogues have been isolated by peroxydisulfate oxidation and were tested for antimalarial activity against Plasmodium yoelli infected mice.

Three-Dimensional Quantitative Structure-Activity Relationship Analysis for Human Pregnane X Receptor for the Prediction of CYP3A4 Induction in Human Hepatocytes: Structure-Based Comparative Molecular Field Analysis

Three-Dimensional Quantitative Structure-Activity Relationship Analysis for Human Pregnane X Receptor for the Prediction of CYP3A4 Induction in Human Hepatocytes: Structure-Based Comparative Molecular Field Analysis

Publication: J Pharm Sci
Software: ADMET Predictor®

The pregnane X receptor [PXR (NR1I2)] induces the expression of xenobiotic metabolic genes and transporter genes. In this study, we aimed to establish a computational method for...

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury

Publication: Front Pharmacol
Software: DILIsym®
Division: DILIsym Services

Inhibition of the bile salt export pump (BSEP) has been linked to incidence of drug-induced liver injury (DILI), presumably by the accumulation of toxic bile acids in the liver.